[Collective of users in the fields of AIDS and drug addiction].

Med Sci (Paris)

Centre d'ethnologie française, Musée national des arts et traditions populaires, France.

Published: April 2004

The extent of mobilization caused by the epidemy of AIDS was underlined many times. Because of a logic of selective dissemination, infection by HIV not only started action of patients and their close relations, but also that of the two most affected social groups : homosexual men and drug users. Existing since almost a century, the collectives of patients have shown various configurations, from consensual groups which developped in the thirties to protestor groups emerging within the seventies. We show here how both in AIDS and drug addiction, the collectives of users multiplied through differentiated public identification choices. In the fight against AIDS, all the forms of mobilization coexist. Concerning drugs usage, actions are less diversified and divide in two main categories: groups of interest and self-help groups.

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/2004204475DOI Listing

Publication Analysis

Top Keywords

aids drug
8
groups
5
[collective users
4
users fields
4
aids
4
fields aids
4
drug addiction]
4
addiction] extent
4
extent mobilization
4
mobilization caused
4

Similar Publications

The current research introduces a model-free ultra-local model (MFULM) controller that utilizes the multi-agent on-policy reinforcement learning (MAOPRL) technique for remotely regulating blood pressure through precise drug dosing in a closed-loop system. Within the closed-loop system, there exists a MFULM controller, an observer, and an intelligent MAOPRL algorithm. Initially, a flexible MFULM controller is created to make adjustments to blood pressure and medication dosages.

View Article and Find Full Text PDF

Background: Adherence to HIV treatment regimens involves the consistent and correct intake of all prescribed medications. The implementation of antiretroviral therapy (ART) program has significantly reduced mortality among adolescents living with HIV. However, adherence to ART is lower among adolescents compared to other sub-populations and even lower in sub-Saharan Africa.

View Article and Find Full Text PDF

CircRNA-loaded DC vaccine in combination with low-dose gemcitabine induced potent anti-tumor immunity in pancreatic cancer model.

Cancer Immunol Immunother

January 2025

National Engineering Laboratory for AIDS Vaccine, School of Life Science, Jilin University, Changchun, China.

Although promising, dendritic cell (DC) vaccines may not suffice to fully inhibit tumor progression alone, mainly due to the short expression time of the antigen in DC vaccines, immunosuppressive tumor microenvironment, and tumor antigenic modulation. Overcoming the limitations of DC vaccines is expected to further enhance their anti-tumor effects. In this study, we constructed a circRNA-loaded DC vaccine utilizing the inherent stability of circular RNA to enhance the expression level and duration of the antigen within the DC vaccine.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Huashan Hospital, Fudan University, Shanghai, Shanghai, China.

Background: Cognition and its two critical proxies, socioeconomic status (SES) and educational attainment (EA), contribute substantially to human health and are heritable. Elucidating the genetic characteristics of SES/EA/Cognition not only helps to understand the innate individual differences in cognition, but also aids in unraveling the biological mechanisms of complex cognitive-related disorders such as Alzheimer's disease (AD). Here, we explored the rare and common protein-coding variants impacting the comprehensive cognition phenotypic spectrum by leveraging large-scale exomes.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by neuronal dysfunction leading to decreased memory and cognitive function. AD research has largely focused on the potential pathogenic role of two disease hallmarks: amyloid beta and phosphorylated tau. However, pharmacological interventions targeting these disease hallmarks have met with limited clinical trial success.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!